Novavax saw the highest growth of 199% in patent filings and 199% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Novavax‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Novavax has been focused on protecting inventions in United States(US) with 39 publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 30% filings and 36% grants. The United States(US), China(CN), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Novavax is filings its patents. Among the top granted patent authorities, Novavax has 39% of its grants in China(CN), 36% in United States(US) and 8% in Japan(JP).
Johnson & Johnson could be the strongest competitor for Novavax
Bacterial infections related patents lead Novavax portfolio followed by viral infections, and middle east respiratory syndrome (mers)
Novavax has highest number of patents in bacterial infections followed by viral infections, middle east respiratory syndrome (mers), severe acute respiratory syndrome (sars), and ebolavirus infections (ebola hemorrhagic fever).
For comprehensive analysis of Novavax's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
